An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

Coronaviruses (CoVs) traffic frequently between species resulting in novel disease outbreaks, most recently exemplified by the newly emerged SARS-CoV-2, the causative agent of COVID-19. Here, we show that the ribonucleoside analog β-d-N -hydroxycytidine (NHC; EIDD-1931) has broad-spectrum antiviral...

Full description

Saved in:
Bibliographic Details
Published inScience translational medicine Vol. 12; no. 541
Main Authors Sheahan, Timothy P, Sims, Amy C, Zhou, Shuntai, Graham, Rachel L, Pruijssers, Andrea J, Agostini, Maria L, Leist, Sarah R, Schäfer, Alexandra, Dinnon, 3rd, Kenneth H, Stevens, Laura J, Chappell, James D, Lu, Xiaotao, Hughes, Tia M, George, Amelia S, Hill, Collin S, Montgomery, Stephanie A, Brown, Ariane J, Bluemling, Gregory R, Natchus, Michael G, Saindane, Manohar, Kolykhalov, Alexander A, Painter, George, Harcourt, Jennifer, Tamin, Azaibi, Thornburg, Natalie J, Swanstrom, Ronald, Denison, Mark R, Baric, Ralph S
Format Journal Article
LanguageEnglish
Published United States 29.04.2020
Subjects
Online AccessGet more information

Cover

Loading…